“退货”及仲裁事项影响持续,实现盈利遥遥无期,百济神州动用超募资金补流丨看财报

钛媒体
14 Nov 2024

11月12日晚间,“国产创新药一哥”百济神州(688235.SH/06160.HK/BGNE.US)发布了2024年第三季度财报,数据显示,公司前三季度营收191.36亿元,同比增长48.63%,归母净亏损36.87亿元,上年同期为亏损38.78亿元,扣非后归母净亏损为39.90亿元,上年同期为亏损67.83亿元。从扣非数据来看,百济神州的亏损数额已大幅收窄,但该股于绩后两个交易日在H股和A股都以...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10